The IASLC, Guardant Health, the Global Lung Cancer Coalition and AstraZeneca announced the Lung Ambition Alliance, a new partnership to eliminate lung cancer as a cause of death.
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00GlobeNewswirehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngGlobeNewswire2019-07-08 02:00:052019-07-08 13:12:35Lung Ambition Alliance launches with goal to double five-year survival in lung cancer by 2025